Richard S. Mitchell is a Hematologist-Oncologist based in Sydney, NSW, Australia. He looks after people dealing with blood-related illnesses and cancers, as well as serious immune system conditions. This can include babies and children, but adults are also seen.
In many cases, care needs to be careful and steady over time. For some people, the focus is on treating a condition such as acute lymphoblastic leukaemia (ALL) or other forms of leukaemia. For others, it’s more about ongoing blood problems like anaemia or aplastic anaemia, where the body’s blood-making can slow down.
Richard also works with primary immune deficiencies. These are conditions where the immune system doesn’t work the way it should. Examples include severe combined immunodeficiency (SCID) and X-linked severe combined immunodeficiency. At times, people may also have problems linked to immune signals, such as autosomal dominant hyper IgE syndrome or hyper IgE syndrome.
Transplant care is also part of the picture. Bone marrow transplant can be a key step for some conditions, and it comes with its own follow-up needs. Chronic graft versus host disease (cGvHD) and graft versus host disease (GvHD) are complications that can happen after transplant, and these can need long-term support. There’s also room for discussion around how risks and benefits are handled, and what monitoring looks like during recovery.
Some patients come in with inherited conditions that affect how the immune system and bone marrow work, such as Fanconi anaemia or congenital aplastic anaemia. Others may have severe neutropenia in childhood, or ongoing infections and immune-related issues. You might see infections like molluscum contagiosum or cytomegalic inclusion disease mentioned in referrals, along with other immune-linked problems.
When people are unwell, it’s not just the diagnosis that matters. It’s the day-to-day management as well. This includes helping families understand what to watch for, how treatment can change, and why follow-up appointments are so important. Cancer care and transplant care can feel overwhelming, so clear explanations and practical steps are a big part of the job.
Richard is also involved in discussions around treatment options that may include newer approaches where they are available. If a clinical trial is relevant, it can be reviewed as part of overall care planning. The goal stays the same: to give safe, thoughtful treatment that fits each person’s situation.